Team:TU Delft/Human-practice

From 2010.igem.org

(Difference between revisions)
(Continue reading:)
(Continue reading:)
Line 11: Line 11:
**[[Team:TU_Delft/Safety/survey|Video Survey]]
**[[Team:TU_Delft/Safety/survey|Video Survey]]
-
*[[Team:TU_Delft/Human-practice/EPAC_pyramid|EPAC pyramid]
+
*[[Team:TU_Delft/Human-practice/EPAC_pyramid|EPAC pyramid]]
-
*[[Team:TU_Delft/Human-practice/Communcation-plan|Communication plan]
+
*[[Team:TU_Delft/Human-practice/Communcation-plan|Communication plan]]

Revision as of 14:01, 25 October 2010

Human Practice

Next to Biological Safety in the laboratory we also considered the influence of our work on the general public. For example, what are the ethical implications of our project? What is the opinion of the general public about synthetic biology? But we also thought about pressing issues such as DNA patenting, and what kind of influence this has on the development of the field of synthetic biology.

Continue reading: